4-Fluoro-2-Methoxy-5-Nitroaniline CAS 1075705-01-9 Purity >99.0% (HPLC) Osimertinib (AZD-9291) Mesylate Intermediate
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 4-Fluoro-2-Methoxy-5-Nitroaniline (CAS: 1075705-01-9) with high quality, intermediate of Osimertinib (AZD-9291) Mesylate (CAS: 1421373-66-1). Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Osimertinib (AZD-9291) Mesylate intermediates, Please contact: alvin@ruifuchem.com
Chemical Name | 4-Fluoro-2-Methoxy-5-Nitroaniline |
Synonyms | AZD-9291 Intermediate; 2-Amino-5-Fluoro-4-Nitroanisole, 4-Fluoro-5-Nitro-o-Anisidine;4-Fluoro-2-Methoxy-5-Nitrobenzenamine |
Stock Status | In Stock, Production Capacity 100 Tons per Year |
CAS Number | 1075705-01-9 |
Molecular Formula | C7H7FN2O3 |
Molecular Weight | 186.14 g/mol |
Melting Point | 128.0 to 132.0℃ |
Density | 1.412±0.06 g/cm3 |
Store Under Inert Gas | Store Under Inert Gas (Nitrogen or Argon) at 2~8℃ |
Sensitive | Air Sensitive |
COA & MSDS | Available |
Place of Origin | Shanghai, China |
Shelf Life | 2 Years When Properly Stored |
Product Categories |
Pharmaceutical Intermediates |
Brand | Ruifu Chemical |
Items | Specifications | Results |
Appearance | Brown Crystalline Powder | Brown Crystalline Powder |
Identification | The Retention Time of Test Sample Major Peak Complies to Reference Standard |
Conforms |
Purity / Analysis Method | >99.0% (HPLC Area) | 99.72% |
Total Impurities | <1.00% | 0.28% |
Melting Point | 128.0~132.0℃ | 130.2℃ |
Water by Karl Fischer | <0.50% | 0.21% |
Infrared Spectrum | Conforms to Structure | Conforms |
NMR Spectrum 1H | Conforms to Structure | Conforms |
Conclusion | The product has been tested and complies with the given specifications | |
Application | Intermediate of Osimertinib (AZD-9291) Mesylate (CAS: 1421373-66-1) |
Note: This product is for scientific research only and shall not be used for other purposes.
Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃) and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
4-Fluoro-2-Methoxy-5-Nitroaniline (CAS: 1075705-01-9) is used as pharmaceutical intermediates, intermediate of Osimertinib (AZD-9291) Mesylate (CAS: 1421373-66-1). AZD-9291 Mesylate is a potent and selective epidermal growth factor receptor (EGFR) inhibitor. AZD-9291 Mesylate is suitable for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have progressed during or after treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) and have been confirmed to have EGFR T790M mutation positive. AZD-9291 Mesylate is highly selective.